Interim Report January - December 2021

STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)October to DecemberNet sales amounted to MSEK 0 (0)Net loss was MSEK -5.7 (-6.9), corresponding to earnings per share of SEK -0.09 (-0.21)Cash flow after …